Low level of plasma DNase is associated with worse clinical outcome in testicular germ cell tumor patients and exogeneous DNase I improves (Leverages) cisplatin treatment efficacy. [PDF]
BackgroundGerm cell tumor (GCT) patients with unfavourable response to first-line therapy still lack reliable diagnostic and effective treatment Detailed correlation of total extracellular DNA (ecDNA), other DNA species and endogenous DNase levels in GCT
Michal Mego +9 more
doaj +2 more sources
ecDNA Inheritance Supports Tumor Heterogeneity and Evolution [PDF]
Abstract Segregation of extrachromosomal DNA (ecDNA) is random and leads to extensive copy-number heterogeneity.
openalex +2 more sources
Extrachromosomal DNA-Driven Oncogene Dosage Heterogeneity Promotes Rapid Adaptation to Therapy in MYCN-Amplified Cancers. [PDF]
Extrachromosomal DNA (ecDNA) amplification enhances intercellular oncogene dosage variability and accelerates tumor evolution by violating foundational principles of genetic inheritance through its asymmetric mitotic segregation.
Montuori G +35 more
europepmc +3 more sources
Breakage fusion bridge cycles drive high oncogene number with moderate intratumoural heterogeneity [PDF]
Oncogene amplification is a key driver of cancer pathogenesis. Both breakage fusion bridge (BFB) cycles and extrachromosomal DNA (ecDNA) can lead to high oncogene copy numbers, but the impact of BFB amplifications on intratumoral heterogeneity, treatment
Siavash Raeisi Dehkordi +29 more
doaj +2 more sources
Current research on tumor fibrosis has focused on cancer‐associated fibroblasts, which may exert dual functions of tumor promotion and inhibition. Little attention has been paid to whether tumor cells themselves can undergo fibrotic transformation and ...
Yinan Li +8 more
openalex +2 more sources
Generation of orthotopic intracranial glioblastoma patient-derived xenograft models: insights into extrachromosomal DNA-driven MYC(N) and PDGFRA oncogene amplification and preliminary therapeutic evaluation [PDF]
Background: This study aimed to establish orthotopic intracranial patient-derived xenograft (PDX) models to investigate molecular and pathological features and to evaluate potential preclinical therapeutic approaches in glioblastoma (GBM). Methods: Fresh
Thi-Anh-Thuy Tran +15 more
doaj +2 more sources
ecDNA hubs drive cooperative intermolecular oncogene expression [PDF]
Extrachromosomal DNA (ecDNA) is prevalent in human cancers and mediates high expression of oncogenes through gene amplification and altered gene regulation1. Gene induction typically involves cis-regulatory elements that contact and activate genes on the same chromosome2,3.
King L. Hung +33 more
openaire +6 more sources
PATH-31. ECDNA PROMOTES TUMORIGENICITY AND INTRATUMORAL HETEROGENEITY IN MEDULLOBLASTOMA [PDF]
Abstract Extrachromosomal circular DNA (ecDNA) is an important driver of aggressive cancers, including medulloblastoma (MB), the most common pediatric brain tumor. To assess the clinical importance of ecDNA in MB, we applied computational methods to detect ecDNA in the genomes of a cohort of 468 MB patients and 31 MB model systems. Among
Owen Chapman +4 more
openalex +2 more sources
Population dynamics of multiple ecDNA types [PDF]
38 pages, 6 main figures, 6 supplementary ...
Elisa Scanu +2 more
openalex +3 more sources
Resolving spatial subclonal genomic heterogeneity of loss of heterozygosity and extrachromosomal DNA in gliomas [PDF]
Mapping the spatial organization of DNA-level somatic copy number changes in tumors can provide insight to understanding higher-level molecular and cellular processes that drive pathogenesis. We describe an integrated framework of spatial transcriptomics,
Michelle G. Webb +10 more
doaj +2 more sources

